Clinical Updates in Alzheimer’s Disease - Treatment for Alzheimer’s Disease: Focus on Anti-amyloid

Enduring Activity: Clinical Updates in Alzheimer’s Disease Symposium - Treatment for Alzheimer’s Disease: Focus on Anti-amyloid
Target Audience
This activity is targeted toward physicians, advanced practice providers, nurses and other clinicians.
Statement of Need
In the care of patients, memory is not always addressed as an integral part of the patient exam unless there is a complaint of memory loss. Therefore, identification of patients with memory loss often is identified later in the course of dementia. This program will equip primary care providers with knowledge of basic cognitive screening tests and brain imaging to identify patients who would benefit from specialized treatment. This would result in earlier diagnosis and treatment of neurodegenerative diseases.
Objectives
At the conclusion of this offering, the participant will be able to:
• Discuss the rationale and mechanism of action of anti-amyloid agents
• Review the eligibility criteria for anti-amyloid agents
• Review the efficacy and risks associated with anti-amyloid agents
Faculty
Greg Cooper, MD, PhD
Memory and Cognitive Disorders Neurologist
Chief, Adult Neurology
Medical Director
Norton Neuroscience Institute Memory Center
Faculty Disclosure
The speaker, Greg Cooper, MD, PhD, has no relevant financial relationships with ineligible companies to disclose.
Planner & Moderator Disclosure
Planners and moderator for this course have no relevant financial relationships with ineligible companies to disclose.
Commercial Support
This activity has not received commercial support.
Physicians
Accreditation
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Designation
Norton Healthcare designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Nursing Credits
For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at [phone] or [e-mail].
Date of Original Release | June 20, 2024
Course Termination Date | June 2026
Contact Information | Center for Continuing Medical Education; [phone] or [e-mail]
Evaluation
www.surveymonk...
Resources
Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, Hendrix S, Selkoe D, Weiner M, Petersen RC, Salloway S. Lecanemab: Appropriate Use Recommendations. J Prev Alzheimers Dis. 2023;10(3):362-377. doi: 10.14283/jpad.2023.30. PMID: 37357276; PMCID: PMC10313141. pubmed.ncbi.nl...
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. PMID: 37459141; PMCID: PMC10352931. pubmed.ncbi.nl...
Join our online community and stay connected with Norton Healthcare for the latest news, events, and resources to support your well-being. ⬇️
📘 Facebook: / nortonhealthcare
📣 X (Twitter): / norton_health
📸 Instagram: / nortonhealth
🔗 LinkedIn: / norton-healthcare
🎥 TikTok: / nortonhealthcare